文献速递胸部CT

基于术前CT的深度学习模型预测肺腺癌患者无病生存期

Preoperative CT-based Deep Learning Model for Predicting Disease-Free Survival in Patients with Lung Adenocarcinomas.
PubMed 文献 · Radiology · 2020-05-12

本研究回顾性开发并验证基于术前CT的深度学习模型预测肺腺癌无病生存期,内外部验证C指数0.74-0.80和0.71-0.78,与临床T分期相当(P > .05),模型输出为独立预后因素(内部验证HR 2.5,外部验证HR 3.6)。

要点

  • 基于术前CT的深度学习模型可预测肺腺癌无病生存期,内外部验证C指数0.71-0.80。
  • 模型输出为独立预后因素,内部验证HR 2.5,外部验证HR 3.6。
  • 模型判别能力与临床T分期相当(P > .05),校准良好(P > .05)。

核心结论

  • 基于胸部CT的深度学习模型可预测接受手术的临床I期肺腺癌患者的无病生存期。

研究设计与样本

  • 回顾性研究,训练集(数据集1)纳入2009至2015年切除的T1-4N0M0腺癌患者800例,外部验证集(数据集2)纳入2014年切除的临床T1-2aN0M0(I期)腺癌患者108例。
  • 深度学习模型从术前CT检查中提取预后信息。

诊断标准与关键数值

  • 数据集1内部验证C指数0.74-0.80,数据集2外部验证C指数0.71-0.78。
  • 临床T分期C指数内部验证0.78,外部验证0.74,模型与临床T分期相比所有P > .05。
  • 模型在所有数据集中校准良好(P > .05)。
  • 多变量Cox回归显示模型分类输出为独立预后因素:内部验证HR 2.5(95%CI:1.03,5.9;P = .04),外部验证HR 3.6(95%CI:1.6,8.5;P = .003)。
  • 除深度学习模型外,仅吸烟状态(HR 3.4;95%CI:1.4,8.5;P = .007)对临床I期腺癌切除后无病生存期预测有额外贡献。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

Background Deep learning models have the potential for lung cancer prognostication, but model output as an independent prognostic factor must be validated with clinical risk factors. Purpose To develop and validate a preoperative CT-based deep learning model for predicting disease-free survival in patients with lung adenocarcinoma. Materials and Methods In this retrospective study, a deep learning model was trained to extract prognostic information from preoperative CT examinations. Data set 1 for training, tuning, and internal validation consisted of patients with T1-4N0M0 adenocarcinoma resected between 2009 and 2015. Data set 2 for external validation included patients with clinical T1-2aN0M0 (stage I) adenocarcinomas resected in 2014. Discrimination was assessed by using Harrell C index and benchmarked against the clinical T category. The Greenwood-Nam-D'Agostino test was used for model calibration. The multivariable-adjusted hazard ratios (HRs) were analyzed with clinical prognostic factors by using the Cox regression. Results Evaluated were 800 patients (median age, 64 years; interquartile range, 56-70 years; 450 women) in data set 1 and 108 patients (median age, 63 years; interquartile range, 57-71 years; 60 women) in data set 2. The C indexes were 0.74-0.80 in the internal validation and 0.71-0.78 in the external validation, both comparable with the clinical T category (0.78 in the internal validation and 0.74 in the external validation; all P > .05). The model exhibited good calibration in all data sets (P > .05). Multivariable Cox regression revealed that model outputs were independent prognostic factors (hazard ratio [HR] of the categorical output, 2.5 [95% confidence interval {CI}: 1.03, 5.9; P = .04] in the internal validation and 3.6 [95% CI: 1.6, 8.5; P = .003] in the external validation). Other than the deep learning model, only smoking status (HR, 3.4; 95% CI: 1.4, 8.5; P = .007) contributed further to prediction of disease-free survival for patients after resection of clinical stage I adenocarcinomas. Conclusion A deep learning model for chest CT predicted disease-free survival for patients undergoing an operation for clinical stage I lung adenocarcinoma. © RSNA, 2020 Online supplemental material is available for this article. See also the editorial by Shaffer in this issue.

来源:Radiology,查看原文。版权归原作者所有。

引用

  1. Kim H, Goo JM, Lee KH, et al. Preoperative CT-based Deep Learning Model for Predicting Disease-Free Survival in Patients with Lung Adenocarcinomas. Radiology. 2020. PMID: 32396042. doi:10.1148/radiol.2020192764

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。